Literature DB >> 22526823

US regional differences in death rates from depression.

Anthony P Polednak1.   

Abstract

BACKGROUND: Studies in a few countries (including the US) have reported that mortality rates in the population from psychiatric disorders are much higher when they are based on all causes of death ("multiple causes" or "mentions") coded on death certificates versus only the underlying cause. Studies appear to be lacking on geographic variation within the US in mortality rates from psychiatric disorders based on multiple causes of death.
METHOD: The present study examined the US age-standardized rate (ASR) for death with depression using multiple causes versus underlying cause alone in each of the Census Bureau's four regions and nine divisions. ASRs for schizophrenia were also examined for comparison.
RESULTS: For the entire US, the ratio of the ASR based on multiple causes to the ASR based on underlying cause was 20.9 for depression and 9.2 for schizophrenia; in analyses by region and division, these ratios showed limited variation. The most consistent finding for both depression and schizophrenia was that ASRs, whether based on multiple causes or only on underlying cause, were highest in the Midwest region (especially the East North Central division) and lowest in the South (and in each of its three divisions). For ASRs (using multiple causes of death) from depression, these regional differences were evident within each of several levels of urbanization. For deaths with depression coded as other than the underlying cause, ASRs for each of the three most common underlying causes (cardiovascular diseases, intentional injuries, and neoplasms) were highest in the Midwest and lowest in the South.
CONCLUSION: Studies are needed to determine if these regional differences in mortality from depression are due to regional differences in: certifier practices (i.e., in assigning causes of death among persons with psychiatric conditions); the prevalence (among persons with psychiatric disorders) of lifestyle-related factors (e.g., tobacco use and obesity) that mediate mortality risks; and/or in unmet need for psychiatric treatment and medical care for other chronic diseases in persons with psychiatric conditions. Similar studies are needed of regional variation within other countries.

Entities:  

Mesh:

Year:  2012        PMID: 22526823     DOI: 10.1007/s00127-012-0503-z

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  29 in total

Review 1.  Socioeconomic position and major mental disorders.

Authors:  Carles Muntaner; William W Eaton; Richard Miech; Patricia O'Campo
Journal:  Epidemiol Rev       Date:  2004       Impact factor: 6.222

2.  Excess mortality from chronic physical disease in psychiatric patients-the forgotten problem.

Authors:  Stephen Kisely
Journal:  Can J Psychiatry       Date:  2010-12       Impact factor: 4.356

3.  Mentally ill Medicare patients less likely than others to receive certain types of surgery.

Authors:  Yue Li; Xueya Cai; Hang Du; Laurent G Glance; Jeffrey M Lyness; Peter Cram; Dana B Mukamel
Journal:  Health Aff (Millwood)       Date:  2011-07       Impact factor: 6.301

4.  Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey.

Authors:  Benjamin G Druss; Liping Zhao; Silke Von Esenwein; Elaine H Morrato; Steven C Marcus
Journal:  Med Care       Date:  2011-06       Impact factor: 2.983

5.  Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication.

Authors:  Philip S Wang; Michael Lane; Mark Olfson; Harold A Pincus; Kenneth B Wells; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  Rates of depression and anxiety in urban and rural Canada.

Authors:  Sarah Romans; Marsha Cohen; Tonia Forte
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-04-09       Impact factor: 4.328

7.  Chronic medical conditions mediate the association between depression and cardiovascular disease mortality.

Authors:  Evan Atlantis; Zumin Shi; Brenda J W H Penninx; Gary A Wittert; Anne Taylor; Osvaldo P Almeida
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-08       Impact factor: 4.328

8.  Prevalence of depression diagnosis and prescription of antidepressants in East and West Germany: an analysis of health insurance data.

Authors:  Anke Bramesfeld; Thomas Grobe; Friedrich Wilhelm Schwartz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-19       Impact factor: 4.328

9.  Psychiatric disorders certified on death certificates in an English population.

Authors:  Michael J Goldacre; Marie E Duncan; Myfanwy Griffith; Paula Cook-Mozaffari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-02-08       Impact factor: 4.328

10.  Assessment of physical illness by mental health clinicians during intake visits.

Authors:  Nicholas Carson; Arlene M Katz; Shan Gao; Margarita Alegría
Journal:  Psychiatr Serv       Date:  2010-01       Impact factor: 3.084

View more
  4 in total

1.  Expanding the efficacy of Project UPLIFT: Distance delivery of mindfulness-based depression prevention to people with epilepsy.

Authors:  Nancy J Thompson; Archna H Patel; Linda M Selwa; Shelley C Stoll; Charles E Begley; Erica K Johnson; Robert T Fraser
Journal:  J Consult Clin Psychol       Date:  2014-12-15

2.  Trend in rates for deaths with mention of schizophrenia on death certificates of US residents, 1999-2010.

Authors:  Anthony P Polednak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-23       Impact factor: 4.328

3.  Trends in bipolar disorder or depression as a cause of death on death certificates of US residents, 1999-2009.

Authors:  Anthony P Polednak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-11-18       Impact factor: 4.328

4.  Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer.

Authors:  Ng Chong Guan; Fabian Termorshuizen; Wijnand Laan; Hugo M Smeets; Nor Zuraida Zainal; René S Kahn; Niek J De Wit; Marco P M Boks
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-10-27       Impact factor: 4.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.